Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 2Phase 4 2Phase 2 2

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 4

Conditions

Venous Thromboembolism 4Neoplasms 4Venous Thrombosis 2Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Malignant Female Reproductive System Neoplasm 1Abdominal Neoplasms 1

Interventions

Dalteparin 8apixaban 6Rivaroxaban 6Heparin, Low-Molecular-Weight 5Tinzaparin 4Enoxaparin 4bemiparin 2abelacimab 2Warfarin 2MAA868 2Aspirin 2reviparin 1isoquercitrin 1edoxaban 1certoparin 1betrixaban 1argatroban 1acarboxyprothrombin 1Phenprocoumon 1Nadroparin 1N(4)-oleylcytosine arabinoside 1Dabigatran 1Acenocoumarol 1AVE 5026 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Venous Thromboembolism × Enoxaparin × Clear all
NCT01583218 2023-08-07

APEX

Alexion Pharmaceuticals, Inc.

Phase 3 Completed
7,513 enrolled 18 charts 1 FDA
Classical hematology

Venous Thromboembolism

NCT04999176 2021-08-10

VALERIA

Science Valley Research Institute

Phase 3 Unknown
440 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00723216 2010-04-05

Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery

Sanofi

Phase 3 Completed
151 enrolled
Classical hematology

Abdominal Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡